Profound Historical Financial Ratios

PROF Stock

USD 7.35 0.08 1.08%

Profound Medical is promptly reporting on over 122 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 1.61, Invested Capital of 0.0, Average Payables of 2.5 M or Stock Based Compensation To Revenue of 0.41 will help investors to properly organize and evaluate Profound Medical Corp financial condition quickly.

Quick Ratio Current Ratio

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

About Profound Financial Ratios Analysis

Profound Medical CorpFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Profound Medical investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Profound financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Profound Medical history.

Profound Medical Financial Ratios Chart

At this time, Profound Medical's EV To Sales is most likely to increase in the upcoming years. The Profound Medical's current Inventory Turnover is estimated to increase to 0.38, while Days Sales Outstanding is projected to decrease to 324.06.

Price To Sales Ratio Ptb Ratio Days Sales Outstanding Book Value Per Share

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Profound Medical Corp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Profound Medical sales, a figure that is much harder to manipulate than other Profound Medical Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Most ratios from Profound Medical's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Profound Medical Corp current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

	2022	2023	2024	2025 (projected)
Days Sales Outstanding	346.59	369.51	424.94	324.06
PTB Ratio	4.27	5.69	5.12	3.51

Days Sales Outstanding Ptb Ratio

Profound Medical fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		0.48	-0.27	-0.29	0.61	0.58	0.73	-0.37	0.48	0.97	0.59	0.75	0.63	0.58	0.63	0.73	0.73	-0.8	-0.44	-0.88	-0.39	0.33	-0.88	-0.75	0.73	0.62
Ptb Ratio	0.48		-0.15	-0.71	0.6	0.58	0.63	-0.12	1.0	0.66	0.58	0.52	0.62	0.59	0.6	0.34	0.61	-0.48	-0.72	-0.54	-0.04	0.06	-0.54	-0.59	0.7	0.55
Days Sales Outstanding	-0.27	-0.15		0.01	-0.13	-0.12	-0.17	0.08	-0.15	-0.23	-0.12	-0.18	-0.13	-0.11	-0.11	-0.2	-0.17	0.16	0.06	0.16	0.27	-0.04	0.15	0.17	-0.11	-0.13
Book Value Per Share	-0.29	-0.71	0.01		-0.83	-0.84	-0.78	-0.01	-0.71	-0.35	-0.84	-0.71	-0.83	-0.85	-0.78	-0.43	-0.75	0.31	0.96	0.47	0.15	0.18	0.48	0.7	-0.74	-0.8
Free Cash Flow Yield	0.61	0.6	-0.13	-0.83		1.0	0.84	0.0	0.6	0.58	1.0	0.97	0.88	1.0	0.79	0.65	0.81	-0.44	-0.83	-0.81	-0.24	-0.15	-0.81	-0.8	0.84	1.0
Operating Cash Flow Per Share	0.58	0.58	-0.12	-0.84	1.0		0.84	0.0	0.58	0.56	1.0	0.96	0.88	1.0	0.8	0.64	0.81	-0.44	-0.84	-0.78	-0.23	-0.15	-0.78	-0.8	0.84	1.0
Average Payables	0.73	0.63	-0.17	-0.78	0.84	0.84		-0.36	0.63	0.69	0.84	0.85	0.93	0.84	0.83	0.78	1.0	-0.56	-0.9	-0.8	-0.38	0.15	-0.8	-0.98	0.85	0.83
Capex To Depreciation	-0.37	-0.12	0.08	-0.01	0.0	0.0	-0.36		-0.12	-0.36	-0.01	-0.11	0.0	0.04	-0.04	-0.36	-0.45	0.31	0.14	0.25	0.19	-0.93	0.26	0.46	0.07	0.02
Pb Ratio	0.48	1.0	-0.15	-0.71	0.6	0.58	0.63	-0.12		0.66	0.58	0.52	0.62	0.59	0.6	0.34	0.61	-0.48	-0.72	-0.54	-0.04	0.06	-0.54	-0.59	0.7	0.55
Ev To Sales	0.97	0.66	-0.23	-0.35	0.58	0.56	0.69	-0.36	0.66		0.56	0.7	0.6	0.55	0.63	0.66	0.7	-0.8	-0.47	-0.85	-0.32	0.34	-0.85	-0.71	0.73	0.58
Free Cash Flow Per Share	0.59	0.58	-0.12	-0.84	1.0	1.0	0.84	-0.01	0.58	0.56		0.96	0.88	1.0	0.8	0.64	0.81	-0.44	-0.84	-0.78	-0.24	-0.15	-0.78	-0.8	0.84	1.0
Roic	0.75	0.52	-0.18	-0.71	0.97	0.96	0.85	-0.11	0.52	0.7	0.96		0.85	0.96	0.8	0.72	0.83	-0.56	-0.74	-0.87	-0.32	-0.01	-0.87	-0.83	0.84	0.98
Inventory Turnover	0.63	0.62	-0.13	-0.83	0.88	0.88	0.93	0.0	0.62	0.6	0.88	0.85		0.89	0.89	0.69	0.89	-0.48	-0.91	-0.75	-0.33	-0.21	-0.75	-0.87	0.93	0.88
Net Income Per Share	0.58	0.59	-0.11	-0.85	1.0	1.0	0.84	0.04	0.59	0.55	1.0	0.96	0.89		0.8	0.63	0.8	-0.44	-0.84	-0.77	-0.23	-0.19	-0.77	-0.79	0.85	1.0
Days Of Inventory On Hand	0.63	0.6	-0.11	-0.78	0.79	0.8	0.83	-0.04	0.6	0.63	0.8	0.8	0.89	0.8		0.69	0.8	-0.46	-0.83	-0.67	-0.43	-0.11	-0.68	-0.8	0.84	0.8
Payables Turnover	0.73	0.34	-0.2	-0.43	0.65	0.64	0.78	-0.36	0.34	0.66	0.64	0.72	0.69	0.63	0.69		0.79	-0.29	-0.59	-0.75	-0.81	0.13	-0.75	-0.86	0.65	0.66
Average Inventory	0.73	0.61	-0.17	-0.75	0.81	0.81	1.0	-0.45	0.61	0.7	0.81	0.83	0.89	0.8	0.8	0.79		-0.57	-0.88	-0.79	-0.38	0.23	-0.8	-0.99	0.8	0.8
Capex To Revenue	-0.8	-0.48	0.16	0.31	-0.44	-0.44	-0.56	0.31	-0.48	-0.8	-0.44	-0.56	-0.48	-0.44	-0.46	-0.29	-0.57		0.37	0.58	-0.05	-0.41	0.58	0.51	-0.64	-0.45
Cash Per Share	-0.44	-0.72	0.06	0.96	-0.83	-0.84	-0.9	0.14	-0.72	-0.47	-0.84	-0.74	-0.91	-0.84	-0.83	-0.59	-0.88	0.37		0.6	0.26	0.08	0.6	0.84	-0.79	-0.8
Pocfratio	-0.88	-0.54	0.16	0.47	-0.81	-0.78	-0.8	0.25	-0.54	-0.85	-0.78	-0.87	-0.75	-0.77	-0.67	-0.75	-0.79	0.58	0.6		0.31	-0.13	1.0	0.82	-0.74	-0.8
Interest Coverage	-0.39	-0.04	0.27	0.15	-0.24	-0.23	-0.38	0.19	-0.04	-0.32	-0.24	-0.32	-0.33	-0.23	-0.43	-0.81	-0.38	-0.05	0.26	0.31		0.01	0.31	0.46	-0.29	-0.27
Capex To Operating Cash Flow	0.33	0.06	-0.04	0.18	-0.15	-0.15	0.15	-0.93	0.06	0.34	-0.15	-0.01	-0.21	-0.19	-0.11	0.13	0.23	-0.41	0.08	-0.13	0.01		-0.14	-0.23	-0.18	-0.17
Pfcf Ratio	-0.88	-0.54	0.15	0.48	-0.81	-0.78	-0.8	0.26	-0.54	-0.85	-0.78	-0.87	-0.75	-0.77	-0.68	-0.75	-0.8	0.58	0.6	1.0	0.31	-0.14		0.83	-0.74	-0.8
Days Payables Outstanding	-0.75	-0.59	0.17	0.7	-0.8	-0.8	-0.98	0.46	-0.59	-0.71	-0.8	-0.83	-0.87	-0.79	-0.8	-0.86	-0.99	0.51	0.84	0.82	0.46	-0.23	0.83		-0.78	-0.79
Income Quality	0.73	0.7	-0.11	-0.74	0.84	0.84	0.85	0.07	0.7	0.73	0.84	0.84	0.93	0.85	0.84	0.65	0.8	-0.64	-0.79	-0.74	-0.29	-0.18	-0.74	-0.78		0.85
Roe	0.62	0.55	-0.13	-0.8	1.0	1.0	0.83	0.02	0.55	0.58	1.0	0.98	0.88	1.0	0.8	0.66	0.8	-0.45	-0.8	-0.8	-0.27	-0.17	-0.8	-0.79	0.85

Click cells to compare fundamentals

Profound Medical Account Relationship Matchups

Profound Medical fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Price To Sales Ratio	48.67	33.57	33.22	24.62	22.16	25.53
Ptb Ratio	3.65	2.86	4.27	5.69	5.12	3.51
Days Sales Outstanding	371.35	74.99	346.59	369.51	424.94	324.06
Book Value Per Share	5.63	3.94	2.5	1.47	1.69	1.61
Free Cash Flow Yield	(0.0949)	(0.0589)	(0.0995)	(0.12)	(0.13)	(0.11)
Operating Cash Flow Per Share	(1.19)	(1.09)	(1.24)	(1.05)	(0.95)	(0.99)
Stock Based Compensation To Revenue	0.3	0.41	1.05	0.63	0.47	0.43
Pb Ratio	3.65	2.86	4.27	5.69	5.12	3.51
Ev To Sales	37.41	24.0	27.48	22.09	19.88	21.14
Free Cash Flow Per Share	(1.21)	(1.12)	(1.24)	(1.05)	(0.95)	(0.99)
Roic	(0.19)	(0.37)	(0.49)	(0.71)	(0.64)	(0.67)
Inventory Turnover	0.72	0.53	0.46	0.4	0.36	0.38
Net Income Per Share	(1.25)	(1.5)	(1.38)	(1.35)	(1.21)	(1.27)
Days Of Inventory On Hand	508.05	690.07	791.93	905.57	815.01	458.2
Payables Turnover	1.13	1.23	1.8	0.86	0.77	0.68
Sales General And Administrative To Revenue	1.04	1.5	1.42	1.27	1.46	1.63
Research And Ddevelopement To Revenue	1.36	2.22	2.2	2.0	2.3	2.51
Cash Per Share	1.33	4.85	3.28	1.24	1.42	1.35
Pocfratio	(17.28)	(10.32)	(8.6)	(7.95)	(9.14)	(9.6)
Interest Coverage	(34.74)	(99.97)	(170.13)	(37.16)	(42.74)	(44.88)
Pfcf Ratio	(16.99)	(10.05)	(8.6)	(7.95)	(9.14)	(9.6)
Days Payables Outstanding	322.31	296.02	202.74	425.25	489.04	803.63
Income Quality	0.95	0.73	0.9	0.78	0.7	0.62
Roe	(0.22)	(0.38)	(0.55)	(0.92)	(0.82)	(0.87)
Ev To Operating Cash Flow	(13.28)	(7.38)	(7.12)	(7.13)	(8.2)	(8.61)
Pe Ratio	(16.44)	(7.52)	(7.74)	(6.2)	(7.14)	(7.49)
Return On Tangible Assets	(0.62)	(0.22)	(0.37)	(0.45)	(0.66)	(0.59)
Ev To Free Cash Flow	(13.06)	(7.19)	(7.12)	(7.13)	(8.2)	(8.61)
Earnings Yield	(0.28)	(0.0945)	(0.0608)	(0.13)	(0.16)	(0.15)
Intangibles To Total Assets	0.0437	0.0475	0.0106	0.0112	0.0128	0.0122
Current Ratio	20.32	18.56	14.82	6.58	5.92	8.39
Tangible Book Value Per Share	5.36	3.74	2.47	1.45	1.67	3.19
Receivables Turnover	0.98	4.87	1.05	0.99	0.89	1.34
Graham Number	12.58	11.53	8.82	6.68	7.69	7.3

Currently Active Assets on Macroaxis

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin
ADA	Cardano
XRP	XRP

When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:

How To Invest In Profound

Details

Is Profound Stock a good investment?

Details

What is Profound Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profound Medical. If investors know Profound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Profound Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.35)

Revenue Per Share

0.38

Quarterly Revenue Growth

0.639

Return On Assets

(0.45)

Return On Equity

(0.90)

The market value of Profound Medical Corp is measured differently than its book value, which is the value of Profound that is recorded on the company's balance sheet. Investors also form their own opinion of Profound Medical's value that differs from its market value or its book value, called intrinsic value, which is Profound Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Profound Medical's market value can be influenced by many factors that don't directly affect Profound Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Profound Historical Financial Ratios

About Profound Financial Ratios Analysis

Profound Medical Financial Ratios Chart

Price To Sales Ratio

Ptb Ratio

Book Value Per Share

Profound Medical fundamentals Correlations

Profound Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Profound Medical fundamentals Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Operating Cash Flow Per Share	+ 1.0	Free Cash Flow Yield
Free Cash Flow Per Share	+ 1.0	Free Cash Flow Yield
Net Income Per Share	+ 1.0	Free Cash Flow Yield
Roe	+ 1.0	Free Cash Flow Yield
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share

Days Payables Outstanding	- 0.99	Average Inventory
Days Payables Outstanding	- 0.98	Average Payables
Capex To Operating Cash Flow	- 0.93	Capex To Depreciation
Cash Per Share	- 0.91	Inventory Turnover
Cash Per Share	- 0.9	Average Payables
Cash Per Share	- 0.88	Average Inventory